Study on the Cholesterol-lowering and Antioxidant Abilities of a Tri-lactobacillus In Vitro

doi:10.13560/j.cnki.biotech.bull.1985.2020-0399

Abstract

Abstract:

In order to obtain a tri-lactobacillus that is easy to colonize in vivo and has strong ability of lowering cholesterol and anti-oxidation,three strains of Lactobacillus casei S1,Enterococcus faecium S4 and Lactobacillus harbinensis S6 were used to form tri-lactobacillus. The artificial gastrointestinal tolerance,cholesterol-lowering ability,yield of γ-aminobutyric acid（GABA）,and antioxidant activity of tri-lactobacillus were investigated. The results showed that the survival rate of tri-lactobacillus was 47.88% and the number of viable bacteria was 1.25×10⁹CFU/mL after 24 h of treatment with artificial gastric intestinal fluid. The total cholesterol removal rate,specific activity of bile salt hydrolase and GABA yield were 73.43%,151.40 U/mg and 1.387 mg/mL,respectively;and the reducing power,superoxide radical clearance rate and hydroxyl radical clearance were 1.52,95.68% and 89.93%,respectively. It was significantly higher than the control group（P < 0.01）. The tolerance of tri-lactobacillus to artificial gastric and intestinal fluid is strong,and it has strong ability of lowering cholesterol and anti-oxidation,thus it can be further developed as functional microecological preparation or health care product.

Key words: tri-lactobacillus, tolerance of artificial gastric intestinal fluid, cholesterol lowering, γ-aminobutyric acid;, antioxidant activity

HUANG Yuan-xia, PENG Chuan-hai, DING Ning, QIU Zhong-ping, LI Xing, ZOU Mei-hui. Study on the Cholesterol-lowering and Antioxidant Abilities of a Tri-lactobacillus In Vitro[J]. Biotechnology Bulletin, 2020, 36(12): 113-120.

Figures/Tables 7

References 26

[1]	张娟, 石超, 王丽娜, 等. 一株植物乳杆菌Lp3对高脂模型大鼠的益生作用[J]. 微生物学报, 2017,57(10):1481-1492.
	Zhang J, Shi C, Wang LN, et al. Probiotic role of Lactobacillus plantarum Lp3 on hyperlipidemia rats[J]. Acta Microbiologica Sinica, 2017,57(10):1481-1492.
[2]	Özogul F, Hamed I. The importance of lactic acid bacteria for the prevention of bacterial growth and their biogenic amines formation:A review[J]. Critical Reviews in Food Science and Nutrition, 2018,58(10):1660-1670. doi: 10.1080/10408398.2016.1277972 URL pmid: 28128651
[3]	Liu H, Yang C, Jing Y, et al. Ability of lactic acid bacteria isolated from mink to remove cholesterol:in vitro and in vivo studies[J]. Canadian Journal of Microbiology, 2013,59(8):563-569. doi: 10.1139/cjm-2013-0200 URL pmid: 23895196
[4]	Khare A. Cholesterol-lowering effects of Lactobacillus species[J]. Current Microbiology, 2020,77(4):638-644. URL pmid: 32020463
[5]	黄燕, 宿玲恰, 吴敬. 重组谷氨酸脱羧酶制备γ-氨基丁酸的工艺条件优化[J]. 生物技术通报, 2016,32(6):199-204.
	Huang Y, Su LQ, Wu J. Optimization of γ-aminobutyric preparation by recombinant glutamate decarboxylase[J]. Biotechnology Bulletin, 2016,32(6):199-204.
[6]	Mohammed A. Exopolysaccharide production by a new Lactobacillus lactis isolated from the fermented milk and its antioxidant properties[J]. Journal of King Saud University - Science, 2020,32(2):1272-1277.
[7]	李欣益, 刘春妍, 黄建, 等. 益生菌V9对高脂饮食诱导的NAFLD大鼠肝功能、氧化应激及脂代谢的影响及作用机制[J]. 中国免疫学杂志, 2019,35(23):2822-2826.
	Li XY, Liu CY, Huang J, et al. Effects of probiotics V9 on liver function, oxidative stress and lipid metabolism in rats with NAFLD induced by high fat diet and its mechanism[J]. Chinese Journal of Immunology, 2019,35(23):2822-2826.
[8]	李晓军, 马跃英, 龚虹, 等. 一种益生菌组合的降胆固醇能力研究[J]. 中国微生态学杂志, 2017,29(6):663-666.
	Li XJ, Ma YJ, Gong H, et al. The cholesterol-reducing ability of a probiotic combination[J]. Chinese Journal of Microecology, 2017,29(6):663-666.
[9]	Flávia C, Susana M. Bacteria of Lactobacillus casei group:characterization, viability as probiotic in food products and their importance for human health[J]. Archivos Latinoamericanos de Nutricion, 2007,57(4):373-380. URL pmid: 18524322
[10]	Mari M, Yasuyuki S, Dong HH, et al. Lactobacillus harbinensis sp. nov, consisted of strains isolated from traditional fermented vegetables‘suan cai’in harbin, northeastern China and Lactobacillus perolens DSM 12745[J]. Systematic and Applied Microbiology, 2005,28(8):146-165.
[11]	Ma C, Tian L, Luo H, et al. Study on the potential cholesterol lowering ability of Enterococcus faecium from human feces[J]. Food Science and Technology, 2020(2):23-28.
[12]	赵芳, 李艳琴, 李彬春. 模拟人体胃肠道环境筛选益生乳杆菌[J]. 微生物学通报, 2016,43(6):1396-1403. doi: 10.13344/j.microbiol.china.150898 URL
	Zhao F, Li YQ, Li BC, et al. Screening of probiotic Lactobacillus in simulated gastrointestinal environment[J]. Microbiology China, 2016,43(6):1396-1403.
[13]	刘端木, 吴怿, 刘沄, 等. 一株产毒曲霉拮抗细菌的筛选、鉴定及抑菌活性研究[J]. 生物技术通报, 2019,35(8):42-50.
	Liu DM, Wu Y, Liu Y, et al. Screening, identification and antifungal properties of a Bacterium with antagonistic activities against Mycotoxin-producing Aspergillus spp.[J]. Biotechnology Bulletin, 2019,35(8):42-50.
[14]	GB / T 5009. 128-2003, 食品中胆固醇的测定方法[S]. 北京: 中国标准出版社, 2003: 135-138.
	GB/T 5009. 128-2003, Method for determination of cholesterol in foods[S]. Beijing: China Standard Press, 2003: 135-138.
[15]	Tanaka H, Hashiba H, Kok J, et al. Bile salt hydrolase of bifidobacterium longum-biochemical and genetic characterization[J]. Appl Environ Microbiol, 2000,66(6):2502-2512. URL pmid: 10831430
[16]	肖婧, 徐亚男, 李琦, 等. 高产γ-氨基丁酸酵母菌的筛选、鉴定及优化[J]. 食品与生物技术学报, 2016,35(10):1093-1099.
	Xiao J, Xu YN, Li Q, et al. Screening, identification and optimizing of γ-Aminobutyric acid production in yeast[J]. Journal of Food Science and Biotechnology, 2016,35(10):1093-1099.
[17]	黄燕燕, 郭均, 黎恒希, 等. 降胆固醇乳酸菌的体外筛选及其降胆固醇机理探讨[J]. 食品科学, 2018,39(6):88-94.
	Huang YY, Guo J, Li HX, et al. In Vitro screening of lactic acid bacteria for cholesterol-lowering activity and the underlying mechanism[J]. Food Science, 2018,39(6):88-94.
[18]	Xiong T, Li X, Guan Q, et al. Starter culture fermentation of Chinese sauerkraut:growth, acidification and metabolic analyses[J]. Food Control, 2014,41(2):122-127.
[19]	Goldin BR, Gorbach SL, Saxelin M, et al. Survival of Lactobacillus species(strain GG)in human gastrointestinal tract[J]. Digestive Diseases and Sciences, 1992,37(1):121-128. URL pmid: 1728516
[20]	刘彦荣. 胆盐水解酶提高乳酸菌肠道定殖能力和黏附特性的研究[D]. 南京:南京师范大学, 2015.
	Liu YR, Research on bile salt hydrolase’s capability to improve the colonization of lactic acid bacteria and the adhesion properties[D]. Nanjing:Nanjing Normal University, 2015.
[21]	韦云路, 刘义, 王瑶, 等. 3株益生菌体外降胆固醇能力及体内降血脂效果评价[J]. 食品科学, 2017,38(23):129-134.
	Wei YL, Liu Y, Wang Y, et al. Cholesterol-lowering ability in vitro and hypolipidemic effect in vivo of three probiotic strains[J]. Food Science, 2017,38(23):129-134.
[22]	印伯星, 瓦云超, 黄玉军, 等. 不同乳酸菌菌株及混合菌株体外降胆固醇的研究[J]. 扬州大学学报:农业与生命科学版, 2020,41(1):44-49, 61.
	Yin BX, Wa YC, Huang YJ, et al. Study on cholesterol reduction in vitro by single and mixed bacteria[J]. Journal of Yangzhou University:Agricultural and Life Science Edition, 2020,41(1):44-49, 61.
[23]	Ishimwe N, Daliri E, Lee B, et al. The perspective on cholesterol-lowering mechanisms of probiotics[J]. Molecular Nutrition & Food Research, 2015,59(1):94-105. URL pmid: 25403164
[24]	何书美, 贾蜜英. 用菌液的还原能力表征酸牛奶的抗氧化活性[J]. 食品科技, 2013,38(2):39-41.
	He SM, Jia MY. Characterization of the antioxidation activity of yoghourt by reductive ability[J]. Food Science and Technology, 2013,38(2):39-41.
[25]	李晓军, 马跃英, 龚虹, 等. 具高抗氧化能力乳酸菌菌株的筛选与鉴定[J]. 中国微生态学杂志, 2018,30(6):663-666.
	Li XJ, Ma YY, Gong H, et al. Screening and identification of Lactic acid bacteria with high antioxidant capacity[J]. Chinese Journal of Microecology, 2018,30(6):663-666.
[26]	Mohammed A, Almal K. Exopolysaccharide production by a new Lactobacillus lactis isolated from the fermented milk and its antioxidant properties[J]. Journal of King Saud University - Science, 2020,32(2):1272-1277.

	胆固醇去除率/%	BSH比活/（U·mg^-1）
三联乳酸菌	73.43±1.22a	151.40±2.82a
对照组	58.21±2.09b	98.77±0.28b

	胆固醇去除率/%	BSH比活/（U·mg^-1）
三联乳酸菌	73.43±1.22a	151.40±2.82a
对照组	58.21±2.09b	98.77±0.28b

去除胆固醇分布	三联乳酸菌
与胆盐共沉淀/（μg·mL^-1）	26.43±0.56
共沉淀占总去除量的比例/%	56.46±0.68
菌体吸收/（μg·mL^-1）	15.54±0.41
菌体吸收占总去除量的比例/%	39.62±0.58
细胞膜结合/（μg·mL^-1）	1.83±0.07
细胞膜结合占总去除量的比例/%	3.90±0.13

去除胆固醇分布	三联乳酸菌
与胆盐共沉淀/（μg·mL^-1）	26.43±0.56
共沉淀占总去除量的比例/%	56.46±0.68
菌体吸收/（μg·mL^-1）	15.54±0.41
菌体吸收占总去除量的比例/%	39.62±0.58
细胞膜结合/（μg·mL^-1）	1.83±0.07
细胞膜结合占总去除量的比例/%	3.90±0.13

相关系数r	Y （酶比活）	X₁ （共沉淀）	X₂ （菌体吸收）	X₃ （细胞膜结合）
Y（酶比活）	1
X₁（共沉淀）	0.898^**	1
X₂（菌体吸收）	-0.528^*	-0.265	1
X₃（细胞膜结合）	-0.033	0.059	0.631^*	1